Embolization of Pelvic Veins in Treatment of Pelvic Congestion Syndrome

Effectiveness of Embolization of Pelvic Veins in Treatment of Pelvic Congestion Syndrome

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03165214

Enrollment

Registered

2017-05-24

Start date

2017-07-01

Completion date

2019-09-30

Last updated

2020-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic Congestive Syndrome

Brief summary

Chronic pelvic pain is defined as chronic or persistent pain perceived in structures related to the pelvis of either men or women for more than 6 months according to The International Association for the Study of Pain. In other words, chronic pelvic pain with associated ovarian vein varicosities is termed pelvic congestion syndrome and is an important but under-diagnosed condition

Interventions

DEVICEcoil

microcoils

DEVICEhystoacryl glue

hystoacryl mixed with lipidol

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

FEMALE

Age

20 Years to 50 Years

Healthy volunteers

Inclusion criteria

* Clinical symptoms of pelvic congestion syndrome documented by Doppler ultrasound * Failed medical treatment.

Exclusion criteria

* Endometriosis. * Uterine fibroids. * Previous pelvic operations. * Urological diseases.

Design outcomes

Primary

Measure	Time frame
The number of treated patients with different interventions	6 months

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026